Trading Signals: EDIT Stock Price Prediction and Forecast (Wed. Feb. 3, 2016 - Fri. Dec. 22, 2023)(EDITAS MEDICIN)
| EDIT latest price $38.9800 (2.84%) ($38.9800 - $38.9800) on Thu. Oct. 14, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 5.19% (three month average) | RSI | 21 | Latest Price | $38.9800(2.84%) | Stocks Behave Similarly | Similar Stock List | Weekly Trend | EDIT declines -14% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support EDIT advance at 0% a week (0% probability) IBB(69%) IWO(63%) IBUY(62%) IWC(62%) IWM(60%) | Factors Impacting EDIT price | EDIT will decline at least -2.595% in a week (0% probabilities). VIXM(-32%) UUP(-16%) VXX(-12%) TBT(-8%) UNG(-1%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.595% (StdDev 5.19%) | Hourly BBV | 0.8 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $1.63(-95.82%) | Resistance Level | $45.99 | 5 Day Moving Average | $37.33(4.42%) | 10 Day Moving Average | $37.86(2.96%) | 20 Day Moving Average | $45.99(-15.24%) | To recent high | -46.5% | To recent low | 9.7% | Market Cap | $2.421b | | | | Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9). The company was founded by Feng Zhang, Jennifer A. Doudna, George McDonald Church, J. Keith Joung and David R. Liu in September 2013 and is headquartered in Cambridge, MA. |